Literature DB >> 30132065

Bone metastasis treatment modeling via optimal control.

Ariel Camacho1, Silvia Jerez2.   

Abstract

Metastatic disease is a lethal stage of cancer progression. It is characterized by the spread of aberrant cells from a primary tumor to distant tissues like the bone. Several treatments are used to deal with bone metastases formation, but they are palliative since the disease is considered incurable. Computational and mathematical models are used to understand the underlying mechanisms of how bone metastasis evolves. In this way, new therapies aiming to reduce or eliminate the metastatic burden in the bone tissue may be proposed. We present an optimal control approach to analyze some common treatments for bone metastasis. In particular, we focus on denosumab treatment, an anti-resorptive therapy, and radiotherapy treatment which has a cell killing action. We base our work in a variant of an existing model introduced by Komarova. The new model incorporates a logistic equation in order to describe the bone metastasis evolution. We provide proofs of existence and uniqueness of solutions to the corresponding optimal control problems for each treatment. Moreover, we present some numerical simulations to analyze the effectiveness of both treatments when different interactions between cancer and bone cells occur. A discussion of the obtained results is provided.

Entities:  

Keywords:  Bone metastasis; Denosumab; Mathematical modeling; Optimal control; Radiotherapy

Mesh:

Substances:

Year:  2018        PMID: 30132065     DOI: 10.1007/s00285-018-1281-3

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  35 in total

1.  Modeling the interactions between osteoblast and osteoclast activities in bone remodeling.

Authors:  Vincent Lemaire; Frank L Tobin; Larry D Greller; Carolyn R Cho; Larry J Suva
Journal:  J Theor Biol       Date:  2004-08-07       Impact factor: 2.691

2.  Model structure and control of bone remodeling: a theoretical study.

Authors:  Peter Pivonka; Jan Zimak; David W Smith; Bruce S Gardiner; Colin R Dunstan; Natalie A Sims; T John Martin; Gregory R Mundy
Journal:  Bone       Date:  2008-04-15       Impact factor: 4.398

3.  An integrative model of prostate cancer interaction with the bone microenvironment.

Authors:  A Farhat; D Jiang; D Cui; E T Keller; T L Jackson
Journal:  Math Biosci       Date:  2017-09-14       Impact factor: 2.144

4.  Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission.

Authors:  Brittany Stephenson; Cristina Lanzas; Suzanne Lenhart; Judy Day
Journal:  J Math Biol       Date:  2017-05-08       Impact factor: 2.259

5.  Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.

Authors:  A Lipton; K Fizazi; A T Stopeck; D H Henry; M R Smith; N Shore; M Martin; S Vadhan-Raj; J E Brown; G E Richardson; F Saad; D A Yardley; K Zhou; A Balakumaran; A Braun
Journal:  Eur J Cancer       Date:  2015-12-13       Impact factor: 9.162

Review 6.  Role of optimal control theory in cancer chemotherapy.

Authors:  G W Swan
Journal:  Math Biosci       Date:  1990-10       Impact factor: 2.144

Review 7.  Biology of bone metastases.

Authors:  Rachel L Theriault; Richard L Theriault
Journal:  Cancer Control       Date:  2012-04       Impact factor: 3.302

8.  Dynamic modeling of bone metastasis, microenvironment and therapy: Integrating parathyroid hormone (PTH) effect, anti-resorptive and anti-cancer therapy.

Authors:  Rui Moura Coelho; João Miranda Lemos; Irina Alho; Duarte Valério; Arlindo R Ferreira; Luís Costa; Susana Vinga
Journal:  J Theor Biol       Date:  2015-12-04       Impact factor: 2.691

9.  The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.

Authors:  David J Brenner
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

10.  Computational modeling of interactions between multiple myeloma and the bone microenvironment.

Authors:  Yan Wang; Peter Pivonka; Pascal R Buenzli; David W Smith; Colin R Dunstan
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.